Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation

NCT: NCT07281521 · ACTIVE_NOT_RECRUITING

NCT IDNCT07281521
StatusACTIVE_NOT_RECRUITING
Start Date2023-02-27
Completion2027-06
SponsorCardioFocus (INDUSTRY)
First posted
Last updated

Brief Summary

The study evaluates the safety and effectiveness of the investigational QuickShot Nav configuration of the CardioWave System for focal catheter ablation of persistent atrial fibrillation (PerAF).

Frequently Asked Questions

What is Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation?

Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation is a clinical trial registered under NCT07281521. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07281521?

The current status of NCT07281521 (Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation) is: ACTIVE_NOT_RECRUITING.

When did Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation start?

Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation started on 2023-02-27.

Related Devices

PMA P150026Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationCardiofocus, Inc. K152310HeartLight Deflectable SheathCardiofocus, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑